Metraipolis › archive › dc_ca5385ecae55

Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays — Europe PMC PMID:39302978

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39302978
DOI
10.1371/journal.ppat.1012554
License (as archived)
CC0-1.0
Archived
2026-10-06T15:19:59.976Z
SHA-256 of the archived text
3fa1bf01ada75e3c5a01d48b5de9fb6302e81a0473eee5df22dec7de7cb9b735
Stable URL of this page
https://metraipolis.com/documento/dc_ca5385ecae55

How to cite

Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays — Europe PMC PMID:39302978 — Europe PMC (en), https://europepmc.org/article/MED/39302978 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ca5385ecae55 (Metraipolis archive dc_ca5385ecae55, sha256 3fa1bf01ada75e3c5a01d48b5de9fb6302e81a0473eee5df22dec7de7cb9b735)
BibTeX
@misc{dcca5385ecae55,
  title = {Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays — Europe PMC PMID:39302978},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39302978},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ca5385ecae55; sha256 3fa1bf01ada75e3c5a01d48b5de9fb6302e81a0473eee5df22dec7de7cb9b735},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/39302978. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Disease associated pathological aggregates of alpha-synuclein (αSynD) exhibit prion-like spreading in synucleinopathies such as Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Seed amplification assays (SAAs) such as real-time quaking-induced conversion (RT-QuIC) have shown high diagnostic sensitivity and specificity for detecting proteopathic αSynD seeds in a variety of biospecimens from PD and DLB patients. However, the extent to which relative proteopathic seed concentrations are useful as indices of a patient's disease stage or prognosis remains unresolved. One feature of current SAAs that complicates attempts to correlate SAA results with patients' clinical and other laboratory findings is their quantitative imprecision, which has typically been limited to discriminating large differences (e.g. 5-10 fold) in seed concentration. We used end-point dilution (ED) RT-QuIC assays to determine αSynD seed concentrations in patient biospecimens and tested the influence of various assay variables such as serial dilution factor, replicate number and data processing methods. The use of 2-fold versus 10-fold dilution factors and 12 versus 4 replicate reactions per dilution reduced ED-RT-QuIC assay error by as much as 70%. This enhanced assay format discriminated as little as 2-fold differences in αSynD seed concentration besides detecting ~2-16-fold seed reductions caused by inactivation treatments. In some scenarios, analysis of the data using Poisson and midSIN algorithms provided more consistent and statistically significant discrimination of different seed concentrations. We applied our improved assay strategies to multiple diagnostically relevant PD and DLB antemortem patient biospecimens, including cerebrospinal fluid, skin, and brushings of the olfactory mucosa. Using ED αSyn RT-QuIC as a model SAA, we show how to markedly improve the inter-assay reproducibility and quantitative accuracy. Enhanced quantitative SAA accuracy should facilitate assessments of pathological seeding activities as biomarkers in proteinopathy diagnostics and prognostics, as well as in patient cohort selection and assessments of pharmacodynamics and target engagement in drug trials.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS pathogens, 2024 (prima pubblicazione 2024-09-20).
Identificativi: PMID 39302978 · PMCID PMC11451978 · DOI 10.1371/journal.ppat.1012554.
Descrittori MeSH principali: Parkinson Disease; alpha-Synuclein.
Pagina: https://europepmc.org/article/MED/39302978 — https://doi.org/10.1371/journal.ppat.1012554. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T15:11:56.434Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.